SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries
9 references·0 citing·40 second hop
Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries (2014)Does deregulation in community pharmacy i…Demand-side policies to encourage the use of generic medicines: an overview (2013)Demand-side policies to encou…The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview (2012)The impact of pharmaceutical …Shortages of medicines: a complex global challenge (2012)Shortages of medicines: a com…Tendering for outpatient prescription pharmaceuticals: What can be learned from current practices in Europe? (2011)Tendering for outpatient pres…Pharmaceutical policies in European countries in response to the global financial crisis (2011)Pharmaceutical policies in Eu…Differences in costs of and access to pharmaceutical products in the EU (2011)Differences in costs of and a…Pharmaceutical pricing policies in a global market (2008)Pharmaceutical pricing polici…A modified model of pharmacists' job stress: The role of organizational, extra-role, and individual factors on work-related outcomes (2008)A modified model of pharmacis…No struggle, no strength: how pharmacists lost their monopoly (1999)No struggle, no strength: how…The Rise of Professionalism: A Sociological Analysis. (1978)The System of Professions (1988)Handbook of Qualitative Research (1994)Deregulating the pharmacy market: the case of Iceland and Norway (2005)Iceland: health system review. (2014)Role Conflict and Ambiguity in Complex Organizations (1970)LISREL 7 : user's reference guide (1989)The measurement and antecedents of affective, continuance and normative commitment to the organization (1990)Antecedents of front‐line managers' perceptions of HR role stressors (2011)Dealing with the “Grumpy Boomers”: re-engaging the disengaged and retaining talent (2014)Antecedents of turnover intention: A meta-analysis study in the United States (2020)Sustaining Generic Medicines Markets in Europe (2006)The Determinants of Mortality (2006)The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China (2020)Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure (2021)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration (2009)Patients’ Perceptions Of Generic Medications (2009)Generic Medicines: Solutions for a Sustainable Drug Market? (2013)The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians (2015)Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2006)THE WORLD MEDICINES SITUATION 2011 (2011)Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries (2013)Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries (2014)Definition and Classification of Generic Drugs Across the World (2015)Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts? (2006)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Financial crisis and austerity measures in Greece: Their impact on health promotion policies and public health care (2013)Overview of external reference pricing systems in Europe (2015)Capital-Market Imperfections and Investment (1997)The price of innovation: new estimates of drug development costs (2003)Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers (2010)Discounts and rebates granted to public payers for medicines in European countries. (2012)Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective (2018)Underuse of generic medicines in Portugal: An empirical study on the perceptions and attitudes of patients and pharmacists (2011)Causes of drug shortages in the legal pharmaceutical framework (2015)Drug shortages in European countries: a trade-off between market attractiveness and cost containment? (2014)Insights into European Drug Shortages: A Survey of Hospital Pharmacists (2015)Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications (2020)
this work references cited by second hop

References

  • 2012Shortages of medicines: a complex global challenge136 cited
  • 2011Pharmaceutical policies in European countries in response to the global financial crisis135 cited
  • 2008A modified model of pharmacists' job stress: The role of organizational, extra-role, and individual factors on work-related outcomes125 cited
  • 2012The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview115 cited
  • 2008Pharmaceutical pricing policies in a global market107 cited
  • 2011Tendering for outpatient prescription pharmaceuticals: What can be learned from current practices in Europe?98 cited
  • 2011Differences in costs of and access to pharmaceutical products in the EU89 cited
  • 2013Demand-side policies to encourage the use of generic medicines: an overview87 cited
  • 1999No struggle, no strength: how pharmacists lost their monopoly47 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work